Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen G Ward

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Current Opinion in Pharmacology|August 7, 2003
Spotlight on new anti-inflammatory drug targets in the immune systemStephen G Ward, Luke A J O'Neill
FEBS Letters|August 24, 2022
The fusion of quantitative molecular proteomics and immune-oncology: a step towards precision medicine in cancer therapeuticsJames Miles, Stephen G Ward, Banafshé Larijani
Immunology|November 24, 2004
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzleGeorge Kolios, Vassilis Valatas, Stephen G Ward
Current Opinion in Pharmacology|July 10, 2012
Spurs in the hunt for new immunomodulatory drug targetsStephen G Ward, Luke A J O'Neill
Immunology Letters|February 22, 2011
Sat-Nav for T cells: Role of PI3K isoforms and lipid phosphatases in migration of T lymphocytesStephen G Ward, John Westwick, Stephanie Harris
The Biochemical Journal|January 23, 2009
Mechanisms of chemokine and antigen-dependent T-lymphocyte navigationStephen G Ward, Federica M Marelli-Berg
Cellular Signalling|July 26, 2005
Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytesClare M Wain, John Westwick, Stephen G Ward
Current Opinion in Pharmacology|October 16, 2009
How does inflammation cause Barrett's metaplasia?Benjamin J Colleypriest, Stephen G Ward, David Tosh
Nature Immunology|December 24, 2002
PI3K comes of ageStephen G Ward, Peter Finan, Melanie J Welham
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Assessing the role of multiple phosphoinositide 3-kinases in chemokine signaling: use of dominant negative mutants controlled by a tetracycline-regulated gene expression systemAdam P Curnock, Yannis Sotsios, Stephen G Ward
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Current Opinion in Pharmacology|August 7, 2003
Spotlight on new anti-inflammatory drug targets in the immune systemStephen G Ward, Luke A J O'Neill
FEBS Letters|August 24, 2022
The fusion of quantitative molecular proteomics and immune-oncology: a step towards precision medicine in cancer therapeuticsJames Miles, Stephen G Ward, Banafshé Larijani
Immunology|November 24, 2004
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzleGeorge Kolios, Vassilis Valatas, Stephen G Ward
Current Opinion in Pharmacology|July 10, 2012
Spurs in the hunt for new immunomodulatory drug targetsStephen G Ward, Luke A J O'Neill
Immunology Letters|February 22, 2011
Sat-Nav for T cells: Role of PI3K isoforms and lipid phosphatases in migration of T lymphocytesStephen G Ward, John Westwick, Stephanie Harris
The Biochemical Journal|January 23, 2009
Mechanisms of chemokine and antigen-dependent T-lymphocyte navigationStephen G Ward, Federica M Marelli-Berg
Cellular Signalling|July 26, 2005
Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytesClare M Wain, John Westwick, Stephen G Ward
Current Opinion in Pharmacology|October 16, 2009
How does inflammation cause Barrett's metaplasia?Benjamin J Colleypriest, Stephen G Ward, David Tosh
Nature Immunology|December 24, 2002
PI3K comes of ageStephen G Ward, Peter Finan, Melanie J Welham
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Assessing the role of multiple phosphoinositide 3-kinases in chemokine signaling: use of dominant negative mutants controlled by a tetracycline-regulated gene expression systemAdam P Curnock, Yannis Sotsios, Stephen G Ward
Pageof 7